Digg It
#1 in Business Subscribe Email Print

You are here: Home > Business > Marketing > Alarming Marketing Trend

Tags

  • drugs
  • challenges
  • combination
  • combination products
  • companies involved

  • Links

  • Individual Health Insurance 101
  • Effective PR: It's About People
  • Let's Communicate - Use Your Cell Phone
  • Digg It - Alarming Marketing Trend

    One key discipline of successful direct marketing has been to test marketing communications tactics to continually improve results. Th
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    ere is now an alarming trend according to a recent survey that we conducted among business-to-business marketers who are readers of Sa
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    es Lead Report.

    Only 24% of the marketing professionals surveyed said they usually or always test their marketing communications tact
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    ics before rolling them out.

    The survey was completed by 280 of 940 subscribers who received and read a special edition of the enewsl
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    tter Sales Lead Report.

    When asked if they test marketing communications tactics before rolling them out:



    • Less than 5% (4.
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    5%) said they always test;

  • Less than 20% (19.5%) said they usually test;

  • 27% reported they occasionally test;

  • Nearly 34
  • ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    (33.7%) said they seldom test;

  • 15% (15.2%) said they never test.



    In other words, nearly half of the survey participants
  • easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    (48.9%) said that they seldom or never test marketing communications tactics before rolling out their campaigns.

    When asked about the
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    reasons for not testing:



    • More than 50% (50.7%) said they had no time for testing;

    • Almost a quarter of those surveyed (
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    24.8%) said they had no budget for testing;

  • More than 16% (16.3%) said they had no systems for tracking test results;

  • Just o
  • ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    er 8% (8.2%) said they had no need for testing.



    The survey further showed that fewer than 5% (4.6%) said they always test and
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    more than 19% (19.5%) said they usually test marketing communications tactics before rolling them out.

    Based on those who do test:

    <
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    l>

  • A little over 41% (41.1%) percent said the audience was the most important thing to test;

  • Nearly 39% (38.7%) said the off
  • cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    er was the most important thing to test;

  • Almost 15% (14.9%) said the copy was the most important thing to test;

  • Just over 5%
  • tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    (5.38%) said the media was the most important thing to test.



    Successful direct marketers have always touted the value of testi
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    ng in making the scientific decisions about their campaigns. In today’s economy, sadly, testing appears to be considered an optional a
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    tivity; one that is used only for very large campaigns or when prospecting for new audiences.

    This is an alarming trend. Eliminating
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    testing because of cost is like playing Russian Roulette with your marketing campaign. Sometimes you’ll be safe, and the campaign wil
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    bring results. But you'll never really understand why. And unfortunately, one major marketing failure could put a massive hole in yo
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    ur growth strategy. †

    Think long term vs. short term to reap the sure-fire benefits that testing will give to your marketing campaign


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.diggit.org.ua/article/29929/diggit-Alarming-Marketing-Trend.html">Alarming Marketing Trend</a>

    BB link (for phorums):
    [url=http://www.diggit.org.ua/article/29929/diggit-Alarming-Marketing-Trend.html]Alarming Marketing Trend[/url]

    Related Articles:

    Five Tips for Writing Better Brochures

    How To Increase Your Profit Online Using Adwords

    Ten Ways to Help You Improve Your Customer Service

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com